Summary
The fund seeks capital appreciation by investing in mid-size companies in the United States.
The investment process starts with companies in the benchmark index and is designed to highlight with above-average earnings growth outlook.
The team uses fundamental analysis to identify companies with a positive catalyst for growth, such as a new product, acquisition, divestiture, restructuring or change in the marketplace. The team also evaluates the roles and capabilities of management.
The fund invests across variou
Link
Directors
Mar 12, 2024- Liana Marante
- Krishna K. Memani
- Keith B. Jarrett
- John Carter
- Jerry A. Webman
- Deborah L. Talbot
Chief Compliance Officer
- Ludmila Chwazik
Fund Manager(s)
Price
Company Name |
Holding |
| Cencora Inc | 2 % |
| Baker Hughes Co | 1.88 % |
| Ares Management Corp | 1.64 % |
| Booz Allen Hamilton Holding Co | 1.64 % |
| Axon Enterprise Inc | 1.55 % |
| Antero Resources Corp | 0.93 % |
| Align Technology Inc | 0.86 % |
| Carlyle Group Inc/The | 0.79 % |
| Alnylam Pharmaceuticals Inc | 0.71 % |
| BioMarin Pharmaceutical Inc | 0.65 % |
| More |
Documents
Performance
YTD
-
3 Year
-5.43%
5 Year
2.66%
Best
47.31%
1999
Worst
-39.36%
2008
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | 9.3% | 6.5% | -10.6% | 13.7% | -20.6% | 17.2% | 4.2% | 8.5% | -3% |
| Q2 | - | -3.3% | 5.8% | -18.9% | 9% | 32.5% | 6.5% | 5.6% | 6.4% | 2.6% |
| Q3 | - | - | -6.7% | -1.9% | -13.1% | 8.7% | -1.9% | 7.5% | 4.7% | 4.9% |
| Q4 | - | - | 1.7% | 1.6% | 2.5% | 2.4% | 3.8% | -19.5% | 6.2% | 1.5% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | -0.1% | 7% | 2.2% | -3.7% | - | - | - | - | - | - | - | - |
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 3% | 6% | -28% | -4% | 35% | 30% | -7% | 29% | 6% |
Alpha
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| HAGCX | - | 3% | 6% | -28% | -4% | 35% | 30% | -7% | 29% | 6% |
| Russell Midcap | - | 4% | 25% | -27% | 12% | 35% | 34% | -6% | 24% | 6% |
| Alpha | - | -2% | -19% | -0% | -16% | 0% | -4% | -1% | 5% | -0% |